Showing results (321-330 of 352) with videos related to
Sort By:
Pageof 36
International Journal of Dermatology|February 12, 2016
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trialsBruce Strober, Bárður Sigurgeirsson, Georg Popp, et al.Lancet (London, England)|August 12, 2018
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trialsKenneth B Gordon, Bruce Strober, Mark Lebwohl, et al.Acta Dermato-Venereologica|February 11, 2022
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance DataAlice B Gottlieb, Atul Deodhar, Iain B Mcinnes, et al.International Journal of Dermatology|January 31, 2025
Psoriasis in People With Skin of Color: An Evidence-Based UpdateMaria-Angeliki Gkini, Mio Nakamura, Andrew F Alexis, et al.The Journal of Allergy and Clinical Immunology|January 24, 2026
Bimekizumab long-term response in psoriasis: Mechanistic insights into efficacy level and durabilityJames G Krueger, Ioana Cutcutache, Mark Lebwohl, et al.Dermatology Online Journal|July 29, 2026
The role of aryl hydrocarbon receptor agonists in the management of inflammatory skin diseases: An expert consensus panelLauren DeBusk, Brooke Bartley, April W Armstrong, et al.Lancet (London, England)|June 15, 2015
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trialsChristopher E M Griffiths, Kristian Reich, Mark Lebwohl, et al.JAMA Dermatology|May 15, 2026
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical TrialMark Lebwohl, Andrew Blauvelt, Cynthia E Kartman, et al.Journal of the American Academy of Dermatology|February 11, 2011
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions, Alan Menter, Neil J Korman, et al.The New England Journal of Medicine|July 10, 2014
Secukinumab in plaque psoriasis--results of two phase 3 trialsRichard G Langley, Boni E Elewski, Mark Lebwohl, et al.Pageof 36